[PDF][PDF] Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

R Flisiak, D Zarębska-Michaluk, J Jaroszewicz… - … = Polish Archives of …, 2020 - ruj.uj.edu.pl
Results The study population was sex-balanced with a small predominance of women, who
were older than men. We observed reduction of age between the first and third time interval (…

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

…, N Janjua, P Jarcuska, J Jaroszewicz… - The Lancet …, 2022 - thelancet.com
Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

…, NZ Janjua, P Jarčuška, J Jaroszewicz… - The lancet …, 2018 - thelancet.com
Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective

J Jaroszewicz, BC Serrano, K Wursthorn… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: The quantifiable level of HBsAg has been suggested as a predictor
of treatment response in chronic hepatitis B. However, there is limited information on HBsAg …

Zespół metaboliczny—nowa definicja i postępowanie w praktyce. Stanowisko PTNT, PTLO, PTL, PTH, PTMR, PTMSŻ, sekcji Prewencji i Epidemiologii PTK,„Klubu 30” …

…, G Dzida, P Jankowski, J Jaroszewicz… - … Tętnicze w Praktyce, 2022 - journals.viamedica.pl
Współistnienie otyłości z podwyższonymi wartościami ciśnienia tętniczego, zaburzeniami
gospodarki węglowodanowej oraz lipidowej, określane jako zespół metaboliczny (ZM), …

Interferon-α–induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection

…, J Wiegand, J Hadem, PV Suneetha, J Jaroszewicz… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Pegylated interferon-α (PEG-IFNα), in combination with ribavirin,
controls hepatitis C virus (HCV) infection in approximately 50% of patients by mechanisms that …

Hepatitis E virus (HEV)‐specific T‐cell responses are associated with control of HEV infection

…, A Gronert, B Bremer, A Markova, J Jaroszewicz… - …, 2012 - Wiley Online Library
Hepatitis E virus (HEV) infection is usually self‐limited but may lead to acute hepatitis and
rarely to fulminant hepatic failure. Persistent HEV infections have recently been described in …

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

…, N Janjua, P Jarcuska, J Jaroszewicz… - The Lancet …, 2023 - thelancet.com
Background The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV)
infection as a public health threat by 2030; existing therapies and prophylaxis …

Metabolic syndrome—A new definition and management guidelines

…, G Dzida, P Jankowski, J Jaroszewicz… - Arterial …, 2022 - journals.viamedica.pl
The joint position paper by Polish Society of Hypertension, Polish Society for the Treatment
of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of …

[HTML][HTML] Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

…, S Lunemann, PV Suneetha, J Jaroszewicz… - PLoS …, 2011 - journals.plos.org
The outcome of viral infections is dependent on the function of CD8+ T cells which are
tightly regulated by costimulatory molecules. The NK cell receptor 2B4 (CD244) is a …